Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
批准号:
10159204
负责人:
DAVID NEMAZEE
金额:
$64.94万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-06-05 至 2025-05-31
关键词:
AblationAnabolismAnimalsAutoimmune DiseasesAutoimmunityB-LymphocytesBiodiversityBiological ProcessBone MarrowChemicalsCodeCommunicationDefectDevelopmentDiseaseDissectionEnzymesFailureGADD45A geneGenesGeneticGlycolipidsGraft RejectionGrantHematopoietic SystemImmune ToleranceImmune systemImmunologyIn VitroInbred MRL lpr MiceKnockout MiceLymphocyteMicroRNAsModelingMolecularMolecular AnalysisMouse StrainsMutant Strains MiceNaturePathway interactionsPatientsPeripheralPlayProcessProteinsResearchRoleTherapeuticTransgenic OrganismsUntranslated RNAautoreactive B cellcancer immunotherapycentral tolerancedesigndiagnostic biomarkerimmunoregulationin vivoinhibitor/antagonistlupus-likemouse modelnovelnovel therapeutic interventionperipheral toleranceplasma cell differentiationpreventsystemic autoimmunitytherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Autoreactive B cells play critical roles in many autoimmune diseases. Multiple immune tolerance
checkpoints exist to remove autoreactive B cells or keep them under control. Defects in these checkpoints
constitute the basis for the development of autoimmune diseases. Despite intensive study, our
understanding of these checkpoints remains incomplete and fragmentary. MicroRNAs (miRNAs) are a new
class of small non-coding RNAs that regulate a large diversity of biological processes. Hundreds of miRNAs
are expressed in the immune system. While some miRNAs have been shown to play important roles in
lymphocyte development and function, the roles of miRNAs in controlling immune tolerance remain poorly
understood. We performed in vivo functional analysis of hundreds of miRNAs in the recently established
IgMb-macroself mouse model and identified miR-148a as an important regulator of B cell central tolerance
and autoimmunity (Nature Immunology 17:433-40, 2016). Further molecular analysis identified 119 target
genes regulated by miR-148a in immature B cells. We examined 4 of these target genes and demonstrated
that 3 of them, Gadd45a, Bim and Pten, regulate B cell central tolerance. In this proposal, we will 1) further
investigate the cellular and molecular mechanisms underlying miR-148a regulation of immune tolerance
and autoimmunity, focusing on its role in controlling various B cell tolerance checkpoints and plasma cell
differentiation; 2) evaluate the possibility of treating systemic autoimmunity through miR-148a ablation and
inhibition by genetic and chemical approaches, respectively, and 3) perform an in vitro functional screen of
the other 115 miR-148a target genes to identify novel regulators of B cell tolerance. Our pilot screen has
identified B4galt5 as a positive hit. As B4galt5 is a major enzyme in the glycolipid biosynthesis pathway, we
speculate that this pathway plays important roles in immune tolerance. Therefore, we will elucidate the
function and mechanism of B4galt5 and the glycolipid biosynthesis pathway in controlling B cell tolerance
and autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of PLD3 in nucleic acid recognition and brain function
-
批准号:10525053
-
项目类别:
-
资助金额:$133.13万
-
财政年份:2022
-
负责人:DAVID NEMAZEE
-
依托单位:
Role of PLD3 in nucleic acid recognition and brain function
-
批准号:10388543
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2021
-
负责人:DAVID NEMAZEE
-
依托单位:
Immune Tolerance in Non-Clonal Immune Systems
-
批准号:9546043
-
项目类别:
-
资助金额:$53.47万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:10190786
-
项目类别:
-
资助金额:$67.91万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:10436822
-
项目类别:
-
资助金额:$67.91万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:10405523
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:9973126
-
项目类别:
-
资助金额:$67.91万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:9810386
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:10630110
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:10159840
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
-
批准号:10405534
-
项目类别:
-
资助金额:$64.94万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:10641828
-
项目类别:
-
资助金额:$63.53万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Germline targeting influenza immunogens
-
批准号:9363697
-
项目类别:
-
资助金额:$141.77万
-
财政年份:2017
-
负责人:DAVID NEMAZEE
-
依托单位:
Germline targeting influenza immunogens
-
批准号:10226016
-
项目类别:
-
资助金额:$139.41万
-
财政年份:2017
-
负责人:DAVID NEMAZEE
-
依托单位:
Designing and optimizing candidate HIV vaccines and boosting protocols
-
批准号:10053304
-
项目类别:
-
资助金额:$96.23万
-
财政年份:2016
-
负责人:DAVID NEMAZEE
-
依托单位:
Designing and optimizing candidate HIV vaccines and boosting protocols
-
批准号:9246148
-
项目类别:
-
资助金额:$96.23万
-
财政年份:2016
-
负责人:DAVID NEMAZEE
-
依托单位:
Analysis of the immunological role of Phospholipase D4
-
批准号:8495932
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2012
-
负责人:DAVID NEMAZEE
-
依托单位:
Analysis of the immunological role of Phospholipase D4
-
批准号:8356431
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2012
-
负责人:DAVID NEMAZEE
-
依托单位:
Functional analysis of Phospholipase D4
-
批准号:7871481
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2009
-
负责人:DAVID NEMAZEE
-
依托单位:
Functional analysis of Phospholipase D4
-
批准号:7739769
-
项目类别:
-
资助金额:$28.49万
-
财政年份:2009
-
负责人:DAVID NEMAZEE
-
依托单位:
海外基金